The clinical and neuropathological features of AD have been attempted to be explained by the hypothesis that amyloid and tau pathology is a secondary consequence of excessive maladaptive plasticity arising in response to remote initiators of AD, which are influenced by many genetic and environmental factors [235]. This evidence concerns the gene MAPT and Alzheimer disease.